期刊文献+

ACE基因rs4353多态性与房颤消融术后复发关系 被引量:4

The Association between Angiotensin Converting Enzyme Gene rs4353 Polymorphism and Atrial Fibrillation Recurrence after Catheter Ablation
原文传递
导出
摘要 目的探讨血管紧张素转换酶(angiotensin converting enzyme,ACE)基因多态性与房颤消融术后复发关系。方法随访2007年1月至2008年7月间在我院行单次房颤导管消融术的房颤患者,术后门诊定期常规心电图及24h动态心电图检查随访。选取ACE基因3个标签单核苷酸多态性(tagging single nucleotide polymorphisms,tSNPs)对房颤患者进行基因分型。结果成功随访150例行房颤消融术的患者(年龄:63.73±11.01岁,24.67%非阵发性房颤),其中复发61例(40.67%),中位随访期为57.50个月。rs4353基因型频率与等位基因频率在复发组与未复发组有统计学差异,其中T等位基因频率在复发组中明显低于未复发组(8.33%vs.19.10%,P=0.003)。CC、TC、TT三组基因型房颤患者复发率分别为54.10%(33/61),33.33%(22/66),22.73%(5/22)(Ptrend=0.003)。rs4353位点T等位基因的加性模型时,每增加一个拷贝的T等位基因,风险是增加前的0.473倍(95%CI:0.284-0.788,P=0.004,P校正=0.012)。进一步校正年龄、性别、体重指数、吸烟和饮酒因素后,T等位基因仍然显著降低房颤复发风险(OR=0.483,95%CI:0.282-0.837,P=0.009,P校正=0.027)。结论 ACE基因rs4353可能与房颤消融术后复发相关。 Objective To investigate the correlation between angiotensin converting enzyme(ACE) variants and atrial fibrillation(AF) recurrence after catheter ablation(CA). Methods Acquired AF patients who received single catheter ablation procedure in our hospital from January 2007 to July 2008 underwent regular follow-up at our cardiology clinic. Standard electrocardiographs(ECGs) and 24-h Holter recordings were performed during follow-up to detect AF recurrence. Three tagging single nucleotide polymorphisms(tSNPs) in ACE gene were genotyped. Results A total of 150 AF patients(mean age 63.73±11.01 years, 24.67% non-paroxysmal AF) with symptomatic drug-refractory AF who underwent single CA procedure were enrolled. 61 patients suffered from AF recurrences after single CA procedure during a median follow-up period of 57.50 months. Of the three tSNPs, frequency of T allele of rs4353 was significantly lower in recurrence group(8.33%) than in non-recurrence group(19.10%)(P=0.003). The recurrence rates of patients with CC, TC, and TT genotype were 54.10%(33/61), 33.33%(22/66), and 22.73%(5/22), respectively(Ptrend=0.003). T allele of rs4353 reduced the risk of AF recurrence post CA in additive model with odds ratio(OR) of 0.473(95%CI: 0.284-0.788, P=0.004, Padjust=0.012). After adjusting for age, sex, body mass index(BMI), drinking and smoking, the significance still remained with OR of 0.483(95%CI: 0.282-0.837, P=0.009, Padjust=0.027). Conclusion ACE gene rs4353 polymorphism might be associated with AF recurrence after CA.
出处 《中国分子心脏病学杂志》 CAS 2014年第3期933-937,共5页 Molecular Cardiology of China
基金 国家自然科学基金(81270259) 上海市科委医学引导项目(114119a8600) 上海市教委上海高校中青年教师国外访学进修计划
关键词 房颤 导管消融 复发 血管紧张素转换酶 基因多态性 Atrial Fibrillation Catheter Ablation Recurrence Angiotensin Converting Enzyme Polymorphism
  • 相关文献

参考文献19

  • 1Ravn LS, Benn M, Nordestgaard BG, et al. Angiotensinogen and ACE gene polymorphisms and risk of atrial fibrillation in the general population. Pharmaeogenet Genomics, 2008;18(6):525- 533.
  • 2Anvari A, Tfirel Z, Schmidt A, et al. Angiotensin-converting enzyme and angiotensin 11 receptor 1 polymorphism in coronary disease and malignant ventricular arrhythmias. Cardiovascular researeh, 1999, 43(4): 879-883.
  • 3RA1ZADA V, SKIPPER B, LUO W, et al. Renin-angiotensin polymorphisms and QTc interval prolongation in end-stage renal disease. Kidney inteRNAtional, 2005, 68(3): 1186-1189.
  • 4Calkins H, Kuck K H, Cappato R, et al. 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-t,p, Definitions, Endpoints, and Research Trial Design A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Europace, 2012, 14(4): 528-606.
  • 5Ouyang F, Tilz R, Chun J, et al. Long-Term Results of Catheter Ablation in Paroxysmal Atrial FibrillationClinical Perspective Lessons From a 5-Year Follow-Up. Circulation, 2010, 122(23): 2368-2377.
  • 6Weerasooriya R, Khairy P, Litalien J, et al. Catheter Ablation for Atrial FibrillationAre Results Maintained at 5 Years of Follow- Up? JouRNAl q/" the Ameriean College of Cardiology, 2011, 57(2): 160-166.
  • 7Husser D, Adams V, Piorkowski C, et al. Chromosome 4q25 variants and atrial fibrillation recurrence after catheter ablation. JouRNAl of the American College of Cardiology, 2010, 55(8): 747-753.
  • 8Parvez B, Vaglio J, Rowan S, et al. Symptomatic response to antiarrhythmic drug therapy is modulated by a common single nucleotide polymorphism in atrial fibrillation. JouRNAl of theAmerican College o['Cardiology, 2012, 60(6): 539-545.
  • 9Shoemaker M B, Muhanmaad R, Parvez B, et al. Common atrial fibrillation risk alleles at 4q25 predict recurrence after catheter-based atrial fibrillation ablation. Heart rhythm, 2013, 10(3): 394.
  • 10Darbar D, Motsinger A A, Ritchie M D, et al. Polymorphism modulates symptomatic response to antiarrhythmic drug therapy in patients with lone atrial fibrillation. Heart Rhythm, 2007, 4(6): 743-749.

同被引文献48

  • 1Ye Erbo lati.Ali Mira,Muhuyati,Wu-Hong Lu,Peng-Yi He,Zhi-Qiang Liu,Yu-Chun Yang.TGF-β1 signal pathway in the regulation of inflammation in patients with atrial fibrillation[J].Asian Pacific Journal of Tropical Medicine,2013,6(12):999-1003. 被引量:14
  • 2周自强,胡大一,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43(7):491-494. 被引量:1398
  • 3Bertaglia E,Tondo C,De Simone A,et al. Does catheter ablation cure atrial fibrillation? Single-procedure outcome of drug-refrac- tory atrial fibrillation ablation:a 6-year multicentre experience[J]. Europace,2010,12(2) : 181-187.
  • 4Vermeer SE,den Heijer T,Koudstaal PJ,et al. Incidence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study[J]. Stroke,2003,34(2):392-396.
  • 5Cai BZ,Gong DM ,Liu Y,et al. Homocysteine inhibits potassium channels in human atrial myocytes [J]. Clinical and experimental pharmacology and physiology, 2007,34 (9) : 851-855.
  • 6Fan J,Cao H,Su L,et al. NT-proBNP,but not ANP and C-reac- tive protein,is predictive of paroxysmal atrial fibrillation in pa- tients undergoing pulmonary vein isolation[J]. Journal of interven- tional cardiac electrophysiology, 2012,33 ( 1 ) : 93-100.
  • 7Solheim E,Off MK,Hoff PI,et al. N-terminal pro-B-type natri- uretic peptide level at long-term follow-up after atrial fibrillation ablation:a marker of reverse atrial remodelling and successful ab- lation[J]. Journal of interventional cardiac electrophysiology,2012, 34(2) : 129-136.
  • 8Uijl DW,Delgado V,Tops LF,et al. Natriuretic peptide levels predict recurrence of atrial fibrillation after radiofrequency catheter ablation[J]. American heart journal, 2011,161 ( 1 ) : 197-203.
  • 9Hussein AA, Saliba Wi, Martin Do, et al.Plasma B-type natriuretic peptide levels and recurrent arrhythmia after successful ablation of lone atrial fibrillation[J].Circulation, 2011,123 ( 19 ) : 2077-2082.
  • 10Yamada T,Murakami Y,Okada T,et al. Plasma atrial natriuretic Peptide and brain natriuretic Peptide levels after radiofrequency catheter ablation of atrial fibrillation[J]. Am J Cardio1,2006,97 (12) : 1741-1744.

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部